Franco Valle is President & VP at Eidos Therapeutics, Inc. (EIDX). They have made 9 open-market trades across 2 companies since 2020, most recently 2024-11-30.
CIK 0001699848
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $229K since 2022, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BMEA | BUY | 2024-06-11 | 2024-06-12 | $4.43 | $111K | +5.3% | +6.9% | +53.1% |
| BMEA | BUY | 2022-11-11 | 2022-11-14 | $7.63 | $31K | -11.3% | -11.8% | +26.5% |
| BMEA | BUY | 2022-01-14 | 2022-01-18 | $8.68 | $87K | -10.6% | -13.8% | -45.3% |
| EIDX | SELL | 2021-01-11 | 2021-01-13 | $125.50 | $627K | N/A | N/A | N/A |
| EIDX | SELL | 2020-11-09 | 2020-11-10 | $74.93 | $243K | +9.8% | +44.1% | N/A |
| EIDX | SELL | 2020-10-07 | 2020-10-09 | $74.97 | $1.6M | -1.2% | +0.4% | +61.6% |
| EIDX | SELL | 2020-04-20 | 2020-04-22 | $49.79 | $100K | -8.6% | -7.0% | -2.4% |
| EIDX | SELL | 2020-03-26 | 2020-03-30 | $48.26 | $241K | -5.4% | -0.0% | -8.4% |
| EIDX | SELL | 2020-03-02 | 2020-03-04 | $52.33 | $157K | -24.3% | -22.2% | -3.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.